Drugs Approved for Multiple Myeloma and Other Plasma Cell Neoplasms
- Abecma (Idecabtagene Vicleucel)
- Alkeran for Injection (Melphalan Hydrochloride)
- Alkeran Tablets (Melphalan)
- Aredia (Pamidronate Disodium)
- BiCNU (Carmustine)
- Bortezomib
- Carfilzomib
- Carmustine
- Carvykti (Ciltacabtagene Autoleucel)
- Ciltacabtagene Autoleucel
- Cyclophosphamide
- Daratumumab
- Daratumumab and Hyaluronidase-fihj
- Darzalex (Daratumumab)
- Darzalex Faspro (Daratumumab and Hyaluronidase-fihj)
- Doxil (Doxorubicin Hydrochloride Liposome)
- Doxorubicin Hydrochloride Liposome
- Elotuzumab
- Elranatamab-bcmm
- Elrexfio (Elranatamab-bcmm)
- Empliciti (Elotuzumab)
- Evomela (Melphalan Hydrochloride)
- Idecabtagene Vicleucel
- Isatuximab-irfc
- Ixazomib Citrate
- Kyprolis (Carfilzomib)
- Lenalidomide
- Melphalan
- Melphalan Hydrochloride
- Mozobil (Plerixafor)
- Ninlaro (Ixazomib Citrate)
- Pamidronate Disodium
- Plerixafor
- Pomalidomide
- Pomalyst (Pomalidomide)
- Revlimid (Lenalidomide)
- Sarclisa (Isatuximab-irfc)
- Selinexor
- Talquetamab-tgvs
- Talvey (Talquetamab-tgvs)
- Teclistamab-cqyv
- Tecvayli (Teclistamab-cqyv)
- Thalidomide
- Thalomid (Thalidomide)
- Velcade (Bortezomib)
- Xpovio (Selinexor)
- Zoledronic Acid
- Zometa (Zoledronic Acid)
Drug Combinations Used in Multiple Myeloma and Other Plasma Cell Neoplasms